Protein Sciences Corp Revenue and Competitors
Estimated Revenue & Valuation
- Protein Sciences Corp's estimated annual revenue is currently $4.7M per year.
- Protein Sciences Corp's estimated revenue per employee is $77,500
Employee Data
- Protein Sciences Corp has 60 Employees.
- Protein Sciences Corp grew their employee count by -12% last year.
Protein Sciences Corp's People
Name | Title | Email/Phone |
---|---|---|
1 | Associate Director | Reveal Email/Phone |
2 | Manufacturing Associate | Reveal Email/Phone |
Protein Sciences Corp Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 1 | 0% | N/A | N/A |
#2 | $4.3M | 17 | -26% | N/A | N/A |
#3 | $9.8M | 66 | -11% | N/A | N/A |
#4 | $1.4M | 9 | 350% | N/A | N/A |
#5 | $16.6M | 107 | -23% | N/A | N/A |
#6 | $4.5M | 29 | -22% | N/A | N/A |
#7 | $1.7M | 11 | 57% | N/A | N/A |
#8 | $2.3M | 15 | 25% | N/A | N/A |
#9 | $0.3M | 3 | 0% | N/A | N/A |
#10 | $4M | 19 | -10% | N/A | N/A |
What Is Protein Sciences Corp?
Protein Sciences Corporation (PSC) is a biopharmaceutical service company headquartered in Meriden, CT. PSC is the world leader in using the Baculovirus Expression Vector System (BEVS) on a commercial scale. The company is the partner of choice for pharmaceutical, biotechnology and genomics companies who seek the fastest, safest way to proceed from a gene target to a commercial vaccine, therapeutic, or screening molecule. We employ 40 people in process development, manufacturing, and management.
keywords:N/AN/A
Total Funding
60
Number of Employees
$4.7M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Protein Sciences Corp News
... Players Chiron Corporation, Protein Sciences Corporation, Astrazeneca PLC, ... and thus important decisions for the growth of the company can be made.
? Pfizer Inc. ? Sanofi S A. ? Protein Science Corporation ? GlaxoSmithKline Plc ? Novartis AG ? Bharat Biotech. Analysis of Cardan Shaft...
GlaxoSmithKline, Protein Sciences Corporation, Sanofi Pasteur, Novartis AG, Seqirus, Merck Sharp & Dohme Corp., and Astellas Pharma US, Inc. Market factors...
(UPDATED: See below.) Vaccine developer Protein Sciences is all over the blogosphere today (see, for instance, items on Pharmalot and the WSJ health blog), thanks to a breathless Bloomberg piece on the little Meriden, Conn., biotech. According to Bloomberg reporter John Lauerman’s article, Prot ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.2M | 63 | 0% | N/A |
#2 | $11.3M | 71 | -5% | N/A |
#3 | $7.5M | 77 | -19% | N/A |
#4 | $26.7M | 92 | 19% | N/A |
#5 | $11.2M | 94 | 3% | N/A |